CoChat

Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement

Open access
US Preventive Services Task Force, Davidson, Karina W., Barry, Michael J., Mangione, Carol M., Cabana, Michael, Caughey, Aaron B., Davis, Esa M., Donahue, Katrina E., Doubeni, Chyke A., Kubik, Martha, Li, Li, Ogedegbe, Gbenga, Pbert, Lori, Silverstein, Michael, Stevermer, James, Tseng, Chien-Wen, Wong, John B. · 2021 · JAMA
Cited by 127

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Importance: Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are used. Pregnant persons with gestational diabetes are at increased risk for maternal and fetal complications, including preeclampsia, fetal macrosomia (which can cause shoulder dystocia and birth injury), and neonatal hypoglycemia. Gestational diabetes has also been associated with an increased risk of several long-term health outcomes in pregnant persons and intermediate outcomes in their offspring. Objective: The USPSTF commissioned a systematic review to evaluate the accuracy, benefits, and harms of screening for gestational diabetes and the benefits and harms of treatment for the pregnant person and infant. Population: Pregnant persons who have not been previously diagnosed with type 1 or type 2 diabetes. Evidence Assessment: The USPSTF concludes with moderate certainty that there is a moderate net benefit to screening for gestational diabetes at 24 weeks of gestation or after to improve maternal and fetal outcomes. The USPSTF concludes that the evidence on screening for gestational diabetes before 24 weeks of gestation is insufficient, and the balance of benefits and harms of screening cannot be determined. Recommendation: The USPSTF recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation. (I statement).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2021.11922

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 19

  1. American College of Obstetricians and Gynecologists, 2018, ACOG Practice Bulletin No. 190 summary: gestational diabetes mellitus., Obstet Gynecol, 131, 406, 10.1097/AOG.0000000000002498 · DOI · Paper page
  2. Casagrande, 2018, Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women., Diabetes Res Clin Pract, 141, 200, 10.1016/j.diabres.2018.05.010 · DOI · Paper page
  3. Lavery, 2017, Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010., BJOG, 124, 804, 10.1111/1471-0528.14236 · DOI · Paper page
  4. Zhou, 2018, Prevalence and trends in gestational diabetes mellitus among women in the United States, 2006-2016., Diabetes, 67, 10.2337/db18-121-OR · DOI
  5. Hartling, 2012, Screening and diagnosing gestational diabetes mellitus., Evid Rep Technol Assess (Full Rep), 1
  6. Farrar, 2016, Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis., BMJ, 354, i4694, 10.1136/bmj.i4694 · DOI · Paper page
  7. Goueslard, 2016, Early cardiovascular events in women with a history of gestational diabetes mellitus., Cardiovasc Diabetol, 15, 15, 10.1186/s12933-016-0338-0 · DOI · Paper page
  8. Deputy, 2018, Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth—United States, 2012-2016., MMWR Morb Mortal Wkly Rep, 67, 1201, 10.15585/mmwr.mm6743a2 · DOI · Paper page
  9. Dennis, 2018, Birth weight and maternal age among American Indian/Alaska Native mothers: a test of the weathering hypothesis., SSM Popul Health, 7, 004-4
  10. Naylor, 1997, Selective screening for gestational diabetes mellitus., N Engl J Med, 337, 1591, 10.1056/NEJM199711273372204 · DOI · Paper page
  11. Kim, 2013, Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009., Am J Public Health, 103, e65, 10.2105/AJPH.2013.301469 · DOI · Paper page
  12. Bimson, 2017, Current trends in the diagnosis and management of gestational diabetes mellitus in the United States., J Matern Fetal Neonatal Med, 30, 2607, 10.1080/14767058.2016.1257603 · DOI
  13. American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics, 2017, Practice Bulletin No. 180: gestational diabetes mellitus., Obstet Gynecol, 130, e17, 10.1097/AOG.0000000000002159 · DOI · Paper page
  14. Curry, 2018, Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement., JAMA, 320, 1163, 10.1001/jama.2018.13022 · DOI · Paper page
  15. Pillay, 2021, Screening for gestational diabetes: updated evidence report and systematic review for the US Preventive Services Task Force., JAMA, 10.1001/jama.2021.10404 · DOI · Paper page
  16. Yang, 2014, A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes., J Transl Med, 12, 290, 10.1186/s12967-014-0290-2 · DOI · Paper page
  17. Vandorsten, 2013, NIH consensus development conference: diagnosing gestational diabetes mellitus., NIH Consens State Sci Statements, 29, 1
  18. American Diabetes Association, 2021, Classification and diagnosis of diabetes: standards of medical care in diabetes—2021., Diabetes Care, 44, S15, 10.2337/dc21-S002 · DOI · Paper page
  19. National Diabetes Data Group, 1995, Diabetes in America

Cited by

See all 127

Metadata

Authors
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Stevermer, J., Tseng, C.-W., & Wong, J. B.
Venue
JAMA
Published
2021-08-10
Volume
326
Issue
6
Pages
531
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W3188111966
Cited by
127
References
20
FWCI
15.27
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement. https://app.cochat.ai/papers/10.1001/jama.2021.11922
The paper
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Stevermer, J., Tseng, C.-W., & Wong, J. B. (2021). Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. https://doi.org/10.1001/jama.2021.11922

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.